vs
Side-by-side financial comparison of Axon Enterprise (AXON) and Hims & Hers Health, Inc. (HIMS). Click either name above to swap in a different company.
Axon Enterprise is the larger business by last-quarter revenue ($796.7M vs $617.8M, roughly 1.3× Hims & Hers Health, Inc.). Hims & Hers Health, Inc. runs the higher net margin — 3.3% vs 0.3%, a 3.0% gap on every dollar of revenue. On growth, Axon Enterprise posted the faster year-over-year revenue change (38.9% vs 28.4%). Axon Enterprise produced more free cash flow last quarter ($155.4M vs $-2.5M). Over the past eight quarters, Hims & Hers Health, Inc.'s revenue compounded faster (49.0% CAGR vs 31.5%).
Axon Enterprise, Inc. is an American company based in Scottsdale, Arizona, that develops weapons and technology products for military, law enforcement, and civilians.
Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.
AXON vs HIMS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $796.7M | $617.8M |
| Net Profit | $2.7M | $20.6M |
| Gross Margin | 57.9% | 71.9% |
| Operating Margin | -6.3% | 1.5% |
| Net Margin | 0.3% | 3.3% |
| Revenue YoY | 38.9% | 28.4% |
| Net Profit YoY | -98.0% | -20.8% |
| EPS (diluted) | $0.02 | $0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $796.7M | $617.8M | ||
| Q3 25 | $710.6M | $599.0M | ||
| Q2 25 | $668.5M | $544.8M | ||
| Q1 25 | $603.6M | $586.0M | ||
| Q4 24 | $573.4M | $481.1M | ||
| Q3 24 | $544.3M | $401.6M | ||
| Q2 24 | $504.1M | $315.6M | ||
| Q1 24 | $460.7M | $278.2M |
| Q4 25 | $2.7M | $20.6M | ||
| Q3 25 | $-2.2M | $15.8M | ||
| Q2 25 | $36.1M | $42.5M | ||
| Q1 25 | $88.0M | $49.5M | ||
| Q4 24 | $136.0M | $26.0M | ||
| Q3 24 | $67.0M | $75.6M | ||
| Q2 24 | $40.8M | $13.3M | ||
| Q1 24 | $133.2M | $11.1M |
| Q4 25 | 57.9% | 71.9% | ||
| Q3 25 | 60.1% | 73.8% | ||
| Q2 25 | 60.4% | 76.4% | ||
| Q1 25 | 60.6% | 73.5% | ||
| Q4 24 | 60.5% | 76.8% | ||
| Q3 24 | 60.8% | 79.2% | ||
| Q2 24 | 60.3% | 81.3% | ||
| Q1 24 | 56.4% | 82.4% |
| Q4 25 | -6.3% | 1.5% | ||
| Q3 25 | -0.3% | 2.0% | ||
| Q2 25 | -0.2% | 4.9% | ||
| Q1 25 | -1.5% | 9.9% | ||
| Q4 24 | -2.6% | 3.9% | ||
| Q3 24 | 4.4% | 5.6% | ||
| Q2 24 | 6.5% | 3.5% | ||
| Q1 24 | 3.5% | 3.6% |
| Q4 25 | 0.3% | 3.3% | ||
| Q3 25 | -0.3% | 2.6% | ||
| Q2 25 | 5.4% | 7.8% | ||
| Q1 25 | 14.6% | 8.4% | ||
| Q4 24 | 23.7% | 5.4% | ||
| Q3 24 | 12.3% | 18.8% | ||
| Q2 24 | 8.1% | 4.2% | ||
| Q1 24 | 28.9% | 4.0% |
| Q4 25 | $0.02 | $0.08 | ||
| Q3 25 | $-0.03 | $0.06 | ||
| Q2 25 | $0.44 | $0.17 | ||
| Q1 25 | $1.08 | $0.20 | ||
| Q4 24 | $1.68 | $0.10 | ||
| Q3 24 | $0.86 | $0.32 | ||
| Q2 24 | $0.53 | $0.06 | ||
| Q1 24 | $1.73 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.7B | $228.6M |
| Total DebtLower is stronger | $1.8B | — |
| Stockholders' EquityBook value | $3.2B | $540.9M |
| Total Assets | $7.0B | $2.2B |
| Debt / EquityLower = less leverage | 0.56× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7B | $228.6M | ||
| Q3 25 | $2.4B | $345.8M | ||
| Q2 25 | $2.1B | $1.1B | ||
| Q1 25 | $2.2B | $273.7M | ||
| Q4 24 | $788.1M | $220.6M | ||
| Q3 24 | $1.0B | $165.5M | ||
| Q2 24 | $968.9M | $129.3M | ||
| Q1 24 | $964.1M | $105.2M |
| Q4 25 | $1.8B | — | ||
| Q3 25 | $2.0B | — | ||
| Q2 25 | $2.0B | — | ||
| Q1 25 | $2.0B | — | ||
| Q4 24 | $680.3M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $3.2B | $540.9M | ||
| Q3 25 | $3.0B | $581.0M | ||
| Q2 25 | $2.7B | $562.7M | ||
| Q1 25 | $2.6B | $549.3M | ||
| Q4 24 | $2.3B | $476.7M | ||
| Q3 24 | $2.1B | $440.1M | ||
| Q2 24 | $1.9B | $362.0M | ||
| Q1 24 | $1.8B | $344.5M |
| Q4 25 | $7.0B | $2.2B | ||
| Q3 25 | $6.7B | $2.2B | ||
| Q2 25 | $6.2B | $1.9B | ||
| Q1 25 | $6.1B | $891.7M | ||
| Q4 24 | $4.5B | $707.5M | ||
| Q3 24 | $4.0B | $602.3M | ||
| Q2 24 | $3.7B | $480.5M | ||
| Q1 24 | $3.6B | $448.1M |
| Q4 25 | 0.56× | — | ||
| Q3 25 | 0.66× | — | ||
| Q2 25 | 0.73× | — | ||
| Q1 25 | 0.79× | — | ||
| Q4 24 | 0.29× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $217.2M | $61.3M |
| Free Cash FlowOCF − Capex | $155.4M | $-2.5M |
| FCF MarginFCF / Revenue | 19.5% | -0.4% |
| Capex IntensityCapex / Revenue | 7.8% | 10.3% |
| Cash ConversionOCF / Net Profit | 79.14× | 2.98× |
| TTM Free Cash FlowTrailing 4 quarters | $75.1M | $57.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $217.2M | $61.3M | ||
| Q3 25 | $60.0M | $148.7M | ||
| Q2 25 | $-91.7M | $-19.1M | ||
| Q1 25 | $25.8M | $109.1M | ||
| Q4 24 | $250.2M | $86.4M | ||
| Q3 24 | $91.3M | $85.3M | ||
| Q2 24 | $82.8M | $53.6M | ||
| Q1 24 | $-15.9M | $25.8M |
| Q4 25 | $155.4M | $-2.5M | ||
| Q3 25 | $33.4M | $79.3M | ||
| Q2 25 | $-114.7M | $-69.5M | ||
| Q1 25 | $932.0K | $50.1M | ||
| Q4 24 | $225.4M | $59.5M | ||
| Q3 24 | $64.8M | $79.4M | ||
| Q2 24 | $71.4M | $47.6M | ||
| Q1 24 | $-32.1M | $11.8M |
| Q4 25 | 19.5% | -0.4% | ||
| Q3 25 | 4.7% | 13.2% | ||
| Q2 25 | -17.2% | -12.8% | ||
| Q1 25 | 0.2% | 8.5% | ||
| Q4 24 | 39.3% | 12.4% | ||
| Q3 24 | 11.9% | 19.8% | ||
| Q2 24 | 14.2% | 15.1% | ||
| Q1 24 | -7.0% | 4.3% |
| Q4 25 | 7.8% | 10.3% | ||
| Q3 25 | 3.7% | 11.6% | ||
| Q2 25 | 3.4% | 9.3% | ||
| Q1 25 | 4.1% | 10.1% | ||
| Q4 24 | 4.3% | 5.6% | ||
| Q3 24 | 4.9% | 1.5% | ||
| Q2 24 | 2.2% | 1.9% | ||
| Q1 24 | 3.5% | 5.0% |
| Q4 25 | 79.14× | 2.98× | ||
| Q3 25 | — | 9.43× | ||
| Q2 25 | -2.54× | -0.45× | ||
| Q1 25 | 0.29× | 2.20× | ||
| Q4 24 | 1.84× | 3.32× | ||
| Q3 24 | 1.36× | 1.13× | ||
| Q2 24 | 2.03× | 4.03× | ||
| Q1 24 | -0.12× | 2.32× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXON
| Software And Sensors Segment | $342.5M | 43% |
| TASER Devices Professional | $264.2M | 33% |
| Personal Sensors | $109.1M | 14% |
| Platform Solutions | $80.9M | 10% |
HIMS
Segment breakdown not available.
